Hywin Holdings Ltd. (“Hywin” or the "Company") (NASDAQ: HYW), a
leading independent wealth management service provider in China,
today announced its unaudited financial results for the first half
of fiscal year 2023 ended December 31, 2022.
First Half of Fiscal Year 2023
Highlights
- Total revenues
increased by 17.6% to RMB1,036.0 million (US$148.8 million) from
RMB881.3 million in the same period of 2021, primarily due to an
increase in transaction value of the products distributed on the
Company’s platform.
- Aggregate transaction value of wealth management products
distributed on the Company’s platform increased by 6.9% to RMB40.1
billion from RMB37.5 billion in the same period of 2021, mainly
attributable to an increase of transaction value in asset-backed
products.
- Income from
operations increased by 15.5% to RMB102.1 million (US$14.7
million) from RMB88.4 million in the same period of 2021,
attributable to the increase in net revenue and improved operating
efficiency.
- Net revenues from asset
management business increased by 79.4% to RMB16.2 million
(US$2.3 million) from RMB9.0 million in the same period of 2021,
primarily due to an increase in assets under management.
- Assets under management for asset management business increased
by 114.3% to RMB7,013.4 million as of December 31, 2022, from
RMB3,272.8 million as of December 31, 2021.
- Number of clients1
increased by 8.7% to 146,418 as of December 31, 2022 from 134,656
as of December 31, 2021.
- Number of active
clients2 increased by 3.9% to 36,742 in the six months
ended December 31, 2022 from 35,366 in the same period of
2021.
- Strong nationwide
coverage: We maintained a strong, nationwide footprint
with 1,738 relationship managers and 177 wealth planning centers
across 88 cities in China as of December 31, 2022.
|
|
|
|
|
|
|
6 months ended, |
6 months ended, |
6 months ended, |
|
Change |
|
12/31/2021 |
12/31/2022 |
12/31/2022 |
|
|
RMB'000 |
RMB'000 |
USD'000 |
|
|
|
|
|
|
|
Total Revenues |
881,256 |
1,035,984 |
148,833 |
|
17.6 |
% |
Income from
Operations |
88,390 |
102,059 |
14,662 |
|
15.5 |
% |
Net
Income |
70,362 |
70,582 |
10,140 |
|
0.3 |
% |
|
|
|
|
|
|
Assets Under
Management |
3,272,810 |
7,013,429 |
1,007,011 |
|
114.3 |
% |
|
|
|
|
|
|
Hywin Health
- Our new Hywin Health business
segment comprises Beijing iLife 3 Technology Co.,
Ltd. and Sincerity and Compassion Health
Management Center, which we acquired during this reporting
period, as well as Grand Doctor Medical Co., Ltd.,
which we acquired in January 2022.
- In light of these acquisitions,
Hywin Health currently operates 5 high-end clinics in Shanghai,
Beijing, Chengdu and Chongqing. Hywin Health’s business model
comprises (i) high-end medical examination services and (ii) health
management services.
- During the reporting period, we
were in initial phase of integrating Hywin Health into our existing
operations and transforming the business model of Hywin
Health.
- Number of Hywin Health
clients3 was 28,763 as of December 31, 2022.
- Number of medical examination
visits was 4,936, which generated revenue of RMB12.4 million in the
first half of fiscal year 2023.
- Number of health management service
clients was 1,178, which generated revenue of RMB25.9 million in
the first half of fiscal year 2023.
- Net revenues were
RMB38.3 million (US$5.5 million) in the first half of fiscal year
2023.
- Net loss was
RMB24.2 million (US$3.5 million) in the first half of fiscal year
2023.
A summary of the operating results of Hywin
Health’s business segment is as follow:
|
6 months ended, |
6 months ended, |
|
12/31/2022 |
12/31/2022 |
|
RMB’000 |
USD’000 |
Net Revenues |
38,304 |
|
5,503 |
|
|
|
|
Operating Costs and
Expenses |
|
|
-Hywin Health costs |
(26,152 |
) |
(3,757 |
) |
-Sales and marketing
expenses |
(9,395 |
) |
(1,350 |
) |
-General and administrative
expenses |
(26,320 |
) |
(3,781 |
) |
Other (expenses)/income |
(634 |
) |
(91 |
) |
Net Loss |
(24,197 |
) |
(3,476 |
) |
|
|
|
|
|
Ms. Wang Dian, Chief Executive Officer and
Director of Hywin, commented, “We are encouraged by Hywin Wealth’s
solid performance and strong financial and operational results in
the first half of fiscal year 2023, which demonstrated its
resilience in the face of macro uncertainties and softening capital
markets, as well as COVID-19-related challenges in China through
the end of 2022. Meanwhile, we continued to make strong progress on
a number of fronts during this period. Hywin Wealth's total client
base increased by 8.7% year-on-year to 146,418 as of the end of the
first half of fiscal year 2023, a record high, and the repeat
investment rate from existing clients remained high at 80.5%. As
for Hywin Health, net revenues in the first half of fiscal year
2023 were RMB38.3 million. Leveraging the unique strengths of our
dual-platform business model and our proactive responses to
evolving customer demands, supported by our strategic product
sourcing capabilities, differentiated services and advanced digital
infrastructures, our efforts are bearing fruit. We are confident
that we will unlock further growth potential as we continue to
execute our strategies.”
Mr. Lawrence Lok, Chief Financial Officer of
Hywin, stated, “This reporting period demonstrated resilient
revenue growth, improved net income, strong cost control, and
strong liquidity position. It is encouraging to see impressive
top-line growth, with revenue increasing by 17.6% year-on-year to
RMB1,036.0 million in the first half of FY2023, despite a slight
decrease of 0.1% in overall operating margin to 9.9% after
factoring in results from Hywin Health. Hywin Health comprises all
of our health management-related strategic acquisitions completed
last year. Hywin Health’s operating loss was RMB23.6 million in
this period, as we were in the initial stage of integrating and
transforming our health businesses. Excluding this, the operating
margin of Hywin Wealth was 12.6%, up 2.6% compared to the same
period of fiscal year 2022. We exhibited strong cost control
capabilities and focused on profitability. Our disciplined
execution also enabled us to balance between achieving business
growth and managing macro risks. We will continue to improve
operational efficiency while seeking new clients and new business
opportunities going forward.”
First Half of Fiscal Year 2023
Financial Results
Net Revenues
Total net revenues in the six months ended
December 31, 2022 increased by 17.6% to RMB1,036.0 million
(US$148.8 million) from RMB881.3 million in the same period of
2021.
- Net revenues from wealth management
services in the six months ended December 31, 2022 increased by
13.4% to RMB970.2 million (US$139.4 million) from RMB855.4 million
in the same period of 2021, in line with our increase in
transaction value.
- Net revenues from asset management
services in the six months ended December 31, 2022 increased by
79.4% to RMB16.2 million (US$2.3 million) from RMB9.0 million in
the same period of 2021, primarily due to an increase in assets
under management.
- Net revenues from health management
services in the six months ended December 31, 2022 were RMB38.3
million (US$5.5 million).
Operating Costs and
Expenses
Total operating costs and expenses in the six
months ended December 31, 2022 increased by 17.8% to RMB933.9
million (US$134.2 million) from RMB792.9 million in the same period
of 2021, in line with our increase in net revenues.
- Cost of compensation and benefits
in the six months ended December 31, 2022 increased by 16.6% to
RMB576.2 million (US$82.8 million) from RMB494.1 million in the
same period of 2021, in line with the increases in the number of
relationship managers and transaction value.
- Cost related to Hywin Health business segment in the six months
ended December 31, 2022 was RMB26.2 million (US$3.8 million).
- Sales and marketing expenses in the
six months ended December 31, 2022 increased by 4.8% to RMB182.6
million (US$26.2 million) from RMB174.2 million in the same period
of 2021, due to increased marketing and sales activities, including
new marketing and sales activities relating to health management
services.
- General and administrative expenses
in the six months ended December 31, 2022 increased by 21.4% to
RMB146.2 million (US$21.0 million) from RMB120.5 million in the
same period of 2021, primarily due to increased personnel expenses
in research, investment and financial advisory, as well as new
expenses related to health management services.
Income from Operations
As a result of the foregoing, income from
operations in the six months ended December 31, 2022 increased by
15.5% to RMB102.1 million (US$14.7 million) from RMB88.4 million in
the same period of 2021.
Net Income
Net income in the six months ended December 31,
2022 increased by 0.3% to RMB70.6 million (US$10.1 million) from
RMB70.4 million in the same period of 2021.
Earnings per ADS
Basic earnings per ADS in the six months ended
December 31, 2022 was RMB2.52 (US$0.36), compared with RMB2.51 in
the same period of 2021.
Diluted earnings per ADS in the six months ended
December 31, 2022 was RMB2.43 (US$0.35), compared with RMB2.43 in
the same period of 2021.
Each ADS represents two of the Company’s
ordinary shares.
Balance Sheet
As of December 31, 2022, the Company had
RMB574.9 million (US$82.5 million) in cash, cash equivalents, and
restricted cash, compared with RMB660.4 million as of June 30,
2022. The decrease was mainly attributable to cash used in Hywin
Health-related acquisitions and a decrease of investors’ deposit in
the restricted cash account.
As of December 31, 2022, the company had
RMB363.1 million (US$52.1 million) in property and equipment, RMB
109.0 million (US$15.6 million) in intangible assets and RMB 293.1
million (US$42.1 million) in goodwill compared with RMB325.1
million in property and equipment, RMB 33.5 million in intangible
assets and RMB 75.2 million in goodwill as of June 30, 2022. The
increase was mainly attributable to the consolidation of newly
acquired Hywin Health companies.
As of December 31, 2022, the company recorded
RMB191.6 million (US$27.5 million) in operating lease right of use
as the company adopted the Accounting Standards Update ("ASU”)
2016-02, Lease (Topic 842) to primarily represent various
facilities under non-cancelable operating leases expiring within
one to ten years.
As of December 31, 2022, the company had RMB21.7
million (US$3.1 million) in deferred tax liability compared with
RMB3.4 million as of June 30, 2022, the increase was primarily due
to the acquisition of Beijing iLife 3 Technology Co., Ltd.
Recent
Developments
On February 22, 2023, Hywin International, a
wholly-owned Hong Kong subsidiary of Hywin Holdings, was elected as
the Vice Chair of the Hong Kong Limited Partnership Fund
Association (HKLPFA), in recognition of Hywin’s intellectual
leadership in alternative asset management and its contributions to
the Hong Kong-domiciled private equity industry.
On January 9, 2023, Hywin Family Office team was
named as one of the “Top 50 China Family Office of the Year” at the
7th Asia Pacific Wealth Forum and won the 2022 International
Private and Family Wealth Management Awards from the Wealth
Management magazine. The award has set a benchmark for excellence
in wealth management in the Asia Pacific region.
On December 14, 2022, Hywin Holdings released
its first sustainability report, showcasing its progress and
commitment to sustainability over 17 years. The report outlines
Hywin's contributions to society, industry, clients, shareholders,
and employees, and highlights achievements in corporate governance,
societal impact, innovation, client services, and talent
development. The report also charts a roadmap for Hywin’s
sustainable growth.
Conference Call
Information
The Company’s management team will hold a Direct
Event conference call on March 23, 2023, at 8:00 A.M. Eastern Time
(8:00 P.M. Beijing Time on the same day) to discuss the financial
results. Details for the conference call are as follows:
Event
Title: |
Hywin Holdings
First Half of Fiscal Year 2023 Earnings Conference Call |
Registration Link: |
https://register.vevent.com/register/BIf227d9cab41a4a72bdcaa5618aa99375 |
All participants must use the link provided
above to complete the online registration process in advance of the
conference call. Upon registering, each participant will receive a
set of participant dial-in numbers, the Direct Event passcode, and
a unique access PIN, which can be used to join the conference
call.
A live and archived webcast of the conference
call will also be available at the Company’s investor relations
website at http://ir.hywinwealth.com.
Exchange
Rate
This press release contains translations of
certain RMB amounts into U.S. dollars at specified rates solely for
the convenience of readers. Unless otherwise noted, all
translations from RMB to U.S. dollars in this press release were
made at a rate of RMB6.96464 to US$1.00, for figures on the balance
sheet as of December 31, 2022, RMB6.96075 to US$1.00 for figures on
the income statement for the six months ended December 31,
2022.
About Hywin Holdings Ltd.
Hywin (NASDAQ: HYW) is a leading independent
wealth management service provider in China focusing on providing
asset allocation advisory services and comprehensive financial
products to high-net-worth clients. The Company’s primary services
are wealth management, asset management, other comprehensive
financial services, and health management services. Wealth
management is currently the Company’s largest business segment, in
which its onshore and offshore solution platforms serve clients
across generations. The Company also offers integrated and high-end
medical examination and health management services to
high-net-worth clients in China, and aims to become a dual-platform
serving clients across market cycles and life cycles. For more
information, please visit https://ir.hywinwealth.com.
Safe Harbor
Statement
This press release contains statements that may
constitute “forward-looking” statements pursuant to the “safe
harbor” provisions of the U.S. Private Securities Litigation Reform
Act of 1995. These forward-looking statements can be identified by
terminology such as “anticipate,” “estimate,” “forecast,” “plan,”
“project,” “potential,” “continue,” “ongoing,” “expect,” “aim,”
“believe,” “intend,” “may,” “should,” “will,” “is/are likely to,”
“could” and similar statements. Statements that are not historical
facts, including statements about the Company's beliefs, plans, and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties. Further
information regarding these and other risks is included in the
Company's filings with the SEC. All information provided in this
press release is as of the date of this press release, and the
Company does not undertake any obligation to update any
forward-looking statement, except as required under applicable
law.
Investor Contact:
Hywin Holdings Ltd.
Email: ir@hywinwealth.com
Media contact:
ICR, LLC
Email: HywinPR@icrinc.com
HYWIN HOLDINGS LTD. CONSOLIDATED STATEMENTS OF INCOME AND
COMPREHENSIVE INCOME |
(In thousands, except for per ADS data and percentages) |
(unaudited) |
|
|
|
|
|
|
|
6 months ended, |
6 months ended, |
6 months ended, |
|
Change |
|
12/31/2021 |
12/31/2022 |
12/31/2022 |
|
|
RMB'000 |
RMB'000 |
USD'000 |
|
Net
Revenues |
|
|
|
|
|
-Wealth management |
855,417 |
|
970,157 |
|
139,376 |
|
|
13.4 |
% |
-Assets management |
9,033 |
|
16,203 |
|
2,328 |
|
|
79.4 |
% |
-Hywin Health |
- |
|
38,304 |
|
5,503 |
|
|
N/A |
-Other |
16,806 |
|
11,320 |
|
1,626 |
|
|
(32.6 |
)% |
Total
Revenue |
881,256 |
|
1,035,984 |
|
148,833 |
|
|
17.6 |
% |
|
|
|
|
|
|
Operating Costs and
Expenses |
|
|
|
|
|
-Compensation and
benefits |
494,127 |
|
576,173 |
|
82,775 |
|
|
16.6 |
% |
-Hywin Health Costs |
- |
|
26,152 |
|
3,757 |
|
|
N/A |
-Share-based compensation |
4,020 |
|
2,804 |
|
403 |
|
|
(30.2 |
)% |
-Sales and marketing
expenses |
174,248 |
|
182,553 |
|
26,226 |
|
|
4.8 |
% |
-General and administrative
expenses |
120,471 |
|
146,243 |
|
21,010 |
|
|
21.4 |
% |
Total Operating Costs
and Expenses |
792,866 |
|
933,925 |
|
134,171 |
|
|
17.8 |
% |
|
|
|
|
|
|
Income from
operations |
88,390 |
|
102,059 |
|
14,662 |
|
|
15.5 |
% |
|
|
|
|
|
|
Other
(expenses)/income |
|
|
|
|
|
-Interest income, net |
1,562 |
|
549 |
|
79 |
|
|
(64.9 |
)% |
-Other non-operation income,
net |
7,837 |
|
(4,559 |
) |
(655 |
) |
|
(158.2 |
)% |
Total Other
Income |
9,399 |
|
(4,010 |
) |
(576 |
) |
|
(142.7 |
)% |
|
|
|
|
|
|
Income before
tax |
97,789 |
|
98,049 |
|
14,086 |
|
|
0.3 |
% |
Income tax expense |
27,427 |
|
27,467 |
|
3,946 |
|
|
0.1 |
% |
Net
income |
70,362 |
|
70,582 |
|
10,140 |
|
|
0.3 |
% |
|
|
|
|
|
|
Less: net loss attributable to
non-controlling interests |
- |
|
2,033 |
|
292 |
|
|
N/A |
Net income/(loss) attributable
to shareholders |
70,362 |
|
68,549 |
|
9,848 |
|
|
(2.6 |
)% |
|
|
|
|
|
|
Other comprehensive
Income |
|
|
|
|
|
-Foreign currency translation
(loss)/gain |
(597 |
) |
2,456 |
|
353 |
|
|
(511.4 |
)% |
Comprehensive
Income |
69,765 |
|
73,038 |
|
10,493 |
|
|
4.7 |
% |
|
|
|
|
|
|
Profit attributable to
shareholders |
70,362 |
|
70,582 |
|
10,140 |
|
|
0.3 |
% |
|
|
|
|
|
|
Income per
ADS |
|
|
|
|
|
Income per ADS basic |
2.51 |
|
2.52 |
|
0.36 |
|
|
0.4 |
% |
Income per ADS diluted |
2.43 |
|
2.43 |
|
0.35 |
|
|
0.0 |
% |
HYWIN HOLDINGS LTD. CONSOLIDATED BALANCE SHEETS |
(unaudited) |
|
|
|
|
|
6/30/2022 |
12/31/2022 |
12/31/2022 |
|
RMB'000 |
RMB'000 |
USD'000 |
ASSETS |
|
|
|
Current assets |
|
|
|
Cash and cash equivalents |
525,136 |
535,615 |
76,905 |
Restricted cash |
135,242 |
39,297 |
5,642 |
Accounts receivable, net |
564,374 |
593,830 |
85,264 |
Due from related parties, net |
66,103 |
36,103 |
5,184 |
Inventories |
- |
10,741 |
1,542 |
Deposits, prepayments and other current assets |
51,204 |
58,240 |
8,363 |
Total Current Assets |
1,342,059 |
1,273,826 |
182,900 |
|
|
|
|
Non-current assets |
|
|
|
Property and equipment, net |
325,112 |
363,130 |
52,139 |
Long term investment |
1,000 |
1,000 |
144 |
Intangible assets, net |
33,548 |
108,969 |
15,646 |
Goodwill |
75,194 |
293,123 |
42,088 |
Long-term prepayments |
5,774 |
6,311 |
906 |
Deferred tax asset |
725 |
725 |
104 |
Operating lease right-of-use assets |
- |
191,588 |
27,509 |
Total Non-current Assets |
441,353 |
964,846 |
138,536 |
|
|
|
|
Total Assets |
1,783,412 |
2,238,672 |
321,436 |
|
|
|
|
LIABILITIES
AND SHAREHOLDERS’ EQUITY |
|
|
Current Liabilities |
|
|
|
Commission payable |
83,205 |
93,399 |
13,411 |
Accounts payable |
- |
28,794 |
4,134 |
Advance from customers |
- |
42,381 |
6,085 |
Investors’ deposit |
132,154 |
27,457 |
3,942 |
Income tax payable |
120,151 |
147,461 |
21,173 |
Due to related parties |
36,172 |
36,622 |
5,258 |
Borrowings |
2,000 |
- |
- |
Consideration payable |
15,300 |
- |
- |
Other payable and accrued liabilities |
390,828 |
472,011 |
67,773 |
Operating lease liabilities |
- |
63,215 |
9,077 |
Total Current Liabilities |
779,810 |
911,340 |
130,853 |
|
|
|
|
Non-current liabilities |
|
|
|
Commission payable-non current |
1,289 |
1,052 |
151 |
Deferred tax liability |
3,400 |
21,693 |
3,115 |
Operating lease liabilities, non-current |
- |
119,975 |
17,226 |
Total Non-current Liabilities |
4,689 |
142,720 |
20,492 |
|
|
|
|
Total Liabilities |
784,499 |
1,054,060 |
151,345 |
|
|
|
|
Mezzanine equity |
|
|
|
Redeemable noncontrolling interest |
30,600 |
30,600 |
4,394 |
|
|
|
|
Total Mezzanine equity |
30,600 |
30,600 |
4,394 |
|
|
|
|
Shareholders' Equity |
|
|
|
Ordinary shares |
36 |
36 |
5 |
Additional paid-in capital |
510,390 |
512,508 |
73,588 |
Statutory reserves |
100,926 |
128,297 |
18,421 |
Accumulated gain |
348,503 |
389,682 |
55,952 |
Noncontrolling interest |
- |
112,575 |
16,164 |
Other comprehensive income |
8,458 |
10,914 |
1,567 |
|
|
|
|
Total Shareholders' equity |
968,313 |
1,154,012 |
165,697 |
|
|
|
|
Total Liabilities, Mezzanine equity and
Shareholder's equity |
1,783,412 |
2,238,672 |
321,436 |
|
|
|
|
_____________________________
1 Clients are those who had conducted at least one transaction
with the Company.2 Active clients are those who purchased products
distributed by the Company during the specified period or those who
maintained as holders of the Company’s products within the given
period.3 Clients are those who have used our health management
services at least once.4 China Foreign Exchange Trade System
USD/RMB mid-point rate on December 31, 2022.5 An appropriately
weighted average exchange rate for the reporting period.
Hywin (NASDAQ:HYW)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Hywin (NASDAQ:HYW)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025